JENNIFER GEE: Open Payments
NPI 1205239944 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 24 payments from 11 companies in 2025. Trend: 2023 $583 · 2024 $14 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $266 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $101 |
| GlaxoSmithKline, LLC. | 1 | $60 |
| Smith+Nephew, Inc. | 1 | $59 |
| Amgen Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $47 |
| Bausch & Lomb Americas Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $32 |
| Cochlear Americas | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
Products named: DUPIXENT, NEFFY, NUCALA, TULA, UBRELVY, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, TEZSPIRE, VYZULTA.
Industry payments across FL — which companies pay providers there.
